Syphilis rates increase by 70% in Europe

Since 2010 there has been 70% increase in reported cases of syphilis in Europe and several other high-income countries, according to a recent report published by the European Centre for Disease Prevention and Control (ECDC).
The data show that in 2017 there was a record high …

More details...

HPV vaccination demonstrates considerable impact

A recent meta-analysis, published in the Lancet, on the impact of the human papillomavirus (HPV) vaccine has shown it has considerable positive impact in high income countries.
The meta-analysis used recent evidence from 65 articles on the effectiveness of the HPV vaccine from 14 high income …

More details...

NHS to roll out gambling addiction services for young people

NHS England has announced its intent to open the first gambling addiction clinics aimed specifically at children and young adults.
The move is part of the NHS’s ‘Long Term Plan’ and looks to tackle the increasing concern over the impact of targeted marketing and online gaming …

More details...

New urine test offers promise for prostate cancer diagnosis

A new urine test has been developed that could provide earlier diagnosis of aggressive prostate cancer and identify those less likely to require invasive post-diagnosis treatment.
The new experimental test, called ‘PUR’ (Prostate Urine Risk), is intended to reduce the number of low-risk prostate cancer patients …

More details...

High visceral body fat increases risk of advanced prostate cancer

Higher levels of visceral fat and thigh subcutaneous fat are associated with an increased risk of advanced and fatal prostate cancer, according to a recent study published in Cancer.
The prospective study of 1832 Icelandic men is the first to directly measure body fat and prostate …

More details...

Breast cancer drug shows promise in treating prostate cancer

Results from a new clinical trial show Olaparib, a gene-targeted drug currently licensed to delay progression of breast and ovarian cancer, can also delay progression of prostate cancer in patients with key genetic mutations.
Olaparib is a PARP inhibitor that targets cancer cells that are unable …

More details...

New blood test offers potential for earlier heart failure diagnosis

Researchers at Queen’s University Belfast have developed a new blood test that offers the potential to provide an earlier and more accurate diagnosis of heart failure than current methods.
At the moment, blood testing for heart failure measures levels of the protein B-type natriuretic peptide (BNP) …

More details...

Ultra-processed food consumption increases CVD risk

Two large European cohort studies, published recently in the BMJ, have shown that the consumption of ultra-processed foods is associated with an increased risk of cardiovascular disease (CVD) and all-cause mortality.
Ultra-processed food refers to food and drink substances that have been through substantial industry …

More details...

Heart and circulatory disease deaths rise for first time in 50 years

Heart and circulatory disease deaths in people under 75 years of age in the UK has risen for the first time in 50 years, according to recent statistics from the British Heart Foundation (BHF).
In 2014, there were 41 042 deaths from conditions related to circulatory …

More details...

Hospital admissions for adolescents with fatty liver disease double since 2013

The number of children and adolescents being treated in hospital for fatty liver disease has more than doubled since 2013, according to recent statistics from NHS Digital.
In the financial year 2013-14, 96 patients aged under 18 years were admitted to hospital with a primary diagnosis …

More details...

Web design and marketing agency Leamington Spa